Cytosorbents (CTSO) Gross Profit Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.95% |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 3.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.45% |
| Mar 31, 2026 | -1.24% |
| Dec 31, 2025 | 8.78% |
| Sep 30, 2025 | 26.83% |
| Jun 30, 2025 | 4.78% |
| Mar 31, 2025 | -9.70% |
| Dec 31, 2024 | 17.77% |
| Sep 30, 2024 | -6.26% |
| Jun 30, 2024 | 8.05% |
| Mar 31, 2024 | 26.00% |
| Dec 31, 2023 | -7.74% |
| Sep 30, 2023 | 55.00% |
| Jun 30, 2023 | 21.71% |
| Mar 31, 2023 | -14.94% |
| Dec 31, 2022 | -24.84% |
| Sep 30, 2022 | -50.43% |
| Jun 30, 2022 | -46.91% |
| Mar 31, 2022 | -18.27% |
| Dec 31, 2021 | -18.76% |
| Sep 30, 2021 | -4.69% |